|
|
|
|
|
|
|
|
-
Solvay Pharmaceuticals is active in more than 50 countries. Our products are available in more than 150 countries.
-
We have our own organizations in Western, Central and Eastern Europe, Russia as well as in Brazil and Mexico. We are expanding in the United States, Japan and the rest of Asia.
-
After the acquisition of Fournier Pharma, we employ a workforce of approximately 9,600 dedicated people.
-
Solvay Pharmaceuticals ranks in the top 40 of pharmaceutical companies.
-
We are active in the following therapeutic areas: cardio-metabolic, neuroscience, influenza vaccines, pancreatic enzymes, gastroenterology and women’s and men’s health.
-
Global sales in 2008 amounts to 2,699 M EUR. REBIT amounts to 509 M EUR.
-
In 2008 we dedicated 16% of our annual sales to research and development.
|
|
|
|
|
|
|
|
